CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) — Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the appointment of Peter […]
Read MoreFor media inquires, please direct your media inquiries to:
If you’re a media professional, please take advantage of our digital Media Kit. You can Download it here.